Start here ↗

Compare care options

Understand the conversation before your consultation.

Learn how commonly discussed metabolic medications differ. Your clinician determines whether any prescription is appropriate for you.

Established GLP-1 pathway

Semaglutide

A prescription GLP-1 medication that may be considered as part of a clinician-guided weight-management plan.

  • Once-weekly formulation may be available
  • Clinical eligibility and dosing are individualized
  • Nutrition, movement, and follow-up remain important

Dual-pathway option

Tirzepatide

A prescription GIP/GLP-1 medication that may be evaluated for eligible patients seeking metabolic support.

  • Once-weekly formulation may be available
  • Health history and contraindications require review
  • Monitoring is determined by the prescriber

Investigational therapy

Retatrutide

Retatrutide remains investigational and is not FDA approved. Vale does not promise access, prescribing, or pharmacy fulfillment.

  • Not an FDA-approved treatment
  • Availability cannot be assumed
  • Discuss approved alternatives with a clinician

This comparison is general education, not medical advice and not a recommendation for any medication. Approved uses, boxed warnings, contraindications, and risks should be reviewed with a licensed clinician.

Clinical eligibility required. Treatment availability, formulation, pricing, and fulfillment depend on the independent licensed clinician’s evaluation, applicable law, and dispensing-pharmacy availability. No medication or outcome is guaranteed.

Find the path that fits your health—not a trend.

Start with a private health intake. A licensed clinician will review your information and determine whether treatment or testing is appropriate.

Begin private intake　↗